Scout | Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

This opportunity is no longer accepting applications.

grant

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

This grant encourages applications for exploratory bioengineering research projects. It aims to support work demonstrating new capabilities or improvements in the quality, speed, effectiveness, functionality, cost, or accessibility of solutions for problems in various areas, including basic biomedical research, pre-clinical or clinical research, healthcare delivery, or accessibility.

Source

Agency: National Institutes of Health

Sub-agency: National Cancer Institute

Program: SBIR

Award

Award Ceiling: $275,000

Funding Amount: $275,000

Dates

Opportunity Released: January 11, 2022

Open for Submission: January 11, 2022

Submission Deadline: January 7, 2025

Application Window Closes: January 7, 2025

Keywords

Bioengineering

Grant

Biomedical Research

Clinical Care

Exploratory Development

Feasibility Study

Healthcare Innovation

Efficacy Improvement

Cost Reduction

Accessibility Solutions

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers